FDA Is Heading And Hosting The First Meeting For IMDRF (International Medical Device Regulators Forum) "SPECIALIZED REGULATORY PATHWAYS" - Meaning Gaps & Loopholes?
"Specialized Regulatory Pathways"? SIGN UP By FEB 16! MARCH 11-15: The International Medical Device Regulators Forum (IMDRF) 2024 sessions will be held in United States & hosted by the United States.
Notice: This is different from the last post!
Apparently the regulators are doing lots of reforms and hosting multiple conferences.
We know these meetings are not for everyone, we are just trying to get this critical information out for the researchers and small groups this may actually interest or help! In reality, it’s pretty interesting to us because these crazy regulators are running some kind of experimentation racket and we like to listen in on their psycho schemes to try to derail them!
We are raising $ for the most serious case ever to stop these damn non vaccine toxic injections. We need your help to sue the regulators to fix their gaps and loopholes, as well as prove they are EXPERIMENTING ON US WITH NO HUMAN RIGHTS PROTECTIONS.
The last post was about a symposium being held February 13-15, 2024:
We asked some pretty good questions worth reading if you have not yet seen them. Hope they answer & stop covid “vaccines” pronto.
New post below is for a “Special Regulatory Pathways” forum held March 11-15, 2024:
Someone in or around DC please attend and report on whatever the heck the Global Experimenters will be doing and discussing about “Special Regulatory Pathways”!
REGISTER: https://events.espinc-usa.com/imdrf032024/4669056
IMDRF 25th Session | March 11-15, 2024 | Washington, DC
The International Medical Device Regulators Forum (IMDRF) 2024 sessions will be held in the United States and hosted by the United States.
The IMDRF Management Committee (MC) invites regulators and professionals from across the IMDRF community to attend the IMDRF MC meetings in Washington, D.C. from March 11 to 15, 2024. We welcome our current members and new Regional Harmonization Initiative and affiliate members.
Washington, D.C. is not just the capital of the US, it is a reflection of the nation’s diverse culture and food, historic architecture, and natural beauty.
WELCOME TO IMDRF 2024
REGISTRATION DEADLINE:
FEBRUARY 16, 2024
COUNTDOWN TO IMDRF MARCH 2024
Questions about Registration & Attending IMDRF?
AGENDA
Please check back soon for updates on the agenda as it is developed.
Virtual attendance will be offered on Day 1 & Day 2.
Day 1 - Joint IMDRF/ Stakeholder (DITTA-GMTA) Workshop - Specialized Regulatory PathwaysRegistrationMonday, March 11, 2024FoyerRegistration & Morning NetworkingMonday, March 11, 2024FoyerGeneral SessionMonday, March 11, 2024AmphitheaterBreakMonday, March 11, 2024FoyerLunch BreakMonday, March 11, 2024FoyerGeneral SessionMonday, March 11, 2024AmphitheaterBreakMonday, March 11, 2024FoyerDay 2 - IMDRF Stakeholder ForumRegistration & Morning NetworkingTuesday, March 12, 2024FoyerGeneral SessionTuesday, March 12, 2024AmphitheaterBreakTuesday, March 12, 2024FoyerLunch BreakTuesday, March 12, 2024FoyerGeneral SessionTuesday, March 12, 2024AmphitheaterBreakTuesday, March 12, 2024Foyer
Time Zone: (UTC-05:00) Eastern Time (US & Canada) [Change Time Zone]
REGISTER HERE: https://events.espinc-usa.com/imdrf032024/begin
ABOUT IMDRF
The IMDRF was established in October 2011 and is a voluntary forum for medical device regulators from different jurisdictions who have agreed to work together to advance international regulatory harmonisation and convergence in the field of medical devices. The IMDRF builds on the strong foundational work of the Global Harmonization Task Force on Medical Devices (GHTF) which was established in 1992 with the United States as one of the founding members.
IMDRF 2024
The International Medical Device Regulators Forum (IMDRF) 2024 sessions will be held in the United States and hosted by the United States.
The IMDRF Management Committee (MC) invites regulators and professionals from across the IMDRF community to attend the IMDRF MC meetings in Washington, D.C. from March 11 to 15, 2024. We welcome our current members and new Regional Harmonization Initiative and affiliate members.
Washington, D.C. is not just the capital of the US, it is a reflection of the nation’s diverse culture and food, historic architecture, and natural beauty.
IMDRF MANAGEMENT COMMITTEE
The IMDRF Management Committee includes representatives from Australia, Brazil, Canada, China, European Union, Japan, Russia, Singapore, South Korea, United Kingdom and the United States.
Argentina, Switzerland and The World Health Organization (WHO) are official observers to the IMDRF.
Affiliate Members are Chile, Cuba, Egypt, Israel, Montenegro, South Africa and Taiwan Food and Drug Administration, Chinese Taipei.
2Personal Information
3Agenda
4Confirmation
By completing this registration, you understand that you may be photographed, taped or recorded during the IMDRF 2024 and that you grant US FDA & IMDRF permission to use your image or voice in all forms and media as permitted by law. You waive the right to inspect or approve versions of your image or voice or the written copy that may be used in connection with either.
US FDA/ IMDRF / ESP accepts no responsibility for loss or damage to personal property at the IMDRF 2024.
The impact of COVID-19
The International Medical Device Regulators Forum (IMDRF) acknowledges the significant impact of the COVID-19 pandemic on all countries and citizens. The use of essential medical devices such as ventilators, oxygen concentrators, syringes and test kits contributed to the efforts of pandemic responses around the world, as with other products regulated in some countries such as surgical face masks.
The IMDRF held a Joint Workshop on COVID-19 in March 2021 and held regular discussions about the impacts, experiences and challenges during the pandemic. Members continue to share information about changes made to regulatory frameworks that aim to assist preparations for future pandemics. Some of these included emergency use or other systems to expedite access and supply of essential medical devices, flexible and pragmatic approaches to regulatory processes such as remote inspections, and publishing information about approval pathways and availability of critical medical devices.
A link to each member country's website is below, where you can find more detailed information.
Affiliate Members
Sidebar navigation
About us
Regulatory Authorities who would like to engage with IMDRF, but do not wish to become or are not Official Observers, may apply to become Affiliate Members. As an Affiliate Member, the regulatory authority will participate in IMDRF by attending “open” meetings and using IMDRF documents in part or in whole as the basis for their own regulatory framework. Affiliate Members may also participate in open Working Groups.
Affiliate Member Representatives
South African Health Products Regulatory Authority (SAHPRA), South Africa
Dr Dimakatso Mathibe
Senior Manager, Medical Devices and Radiation Control
South African Health Products Regulatory Authority
Email: dimakatso.mathibe@sahpra.org.zaMs Portia Nkambule
Chief Regulatory Officer
South African Health Products Regulatory Authority
Email: portia.nkambule@sahpra.org.za
Taiwan Food and Drug Administration (TFDA), Chinese Taipei
Ms Cheng-Ning Wu
Senior Technical Specialist
Division of Medical Devices and Cosmetics
Email: emilywu@fda.gov.twMr Hsiu-Te Lin
Section Chief
Division of Medical Devices and Cosmetics
Email: shoulder0705@fda.gov.tw
Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos (CECMED), Cuba
Dr Mario Cesar Muñiz Ferrer
Head of Medical Devices Department
Email: mario@cecmed.cuMSc Yadira Alvarez Rodriguez
Specialist of Medical Devices Department
Email: yadira@cecmed.cu
Egyptian Drug Authority (EDA), Egypt
Dr Miriam Boles
Head of the Central Administration of Medical Devices (CAMD)
Email: miriam.boles@edaegypt.gov.egDr Sondos Moshtohry
Office of the Chairman
Email: sondos.moshtohry@edaegypt.gov.eg
Medical Technologies, Health Information, Innovation and Research (MTIIR), Israel
Dr Sarit Sivan
Head of the Medical Device Division
Email: sarit.sivan@moh.gov.ilDr Anat Boehm-Cagan
Head of Medical Technologies Regulation and Regulatory Partnerships
Email: anat.boehm-cagan@moh.gov.il
Institute for Medicines and Medical Devices (CinMED), Montenegro
Mira Kontić LL.M.
Deputy Managing Director
Email: Mira.Kontic@cinmed.meMaja Petrović, PharmD
Medical Devices Expert
Email: Maja.Petrovic@cinmed.me
Public Health Institute (ISP), Chile
Maria Cecilia López
Head of the Medical Device Registration Office
Email: mclopez@ispch.clCatalina Valdés
Head of Medical Technovigilance Office
Email: cvaldes@ispch.cl
Information document
IMDRF/MC/N80
IMDRF 24th Session Workshop: White Paper on Specialized Regulatory Pathways
18 December 2023
We are raising $ for the most serious case ever to stop these damn non vaccine toxic injections. We need your help to sue the regulators to fix their gaps and loopholes, as well as prove they are EXPERIMENTING ON US WITH NO HUMAN RIGHTS PROTECTIONS.
Geez, is this a commercial?.
The Schwabian goals tell you everything you need to know: "international regulatory harmonisation and convergence..."
By moving a clearly WEF/UN program under the umbrella of the US FDA, TPTB hope to avoid the links to the real evil behind the curtain. Many still look to the US FDA as a bastion of truth and honesty when, in fact, it is the center of corruption for the US governmental Med Inc Complex.
This project to enslave all humans by the 0.001% (while killing off 90% of us) is so massive and so far along that I despair that it can be stopped.